BioMarin Pharmaceutical Inc
BMRN· Nasdaq
BMRNBioMarin Pharmaceutical Inc
Source filing unavailable
derived · Computed from the longer spans the company filed.
| Metric | Q4 2011dderived from reported figures | Q4 2010dderived from reported figures | Q4 2009dderived from reported figures |
|---|---|---|---|
| Revenue | $107.85M | $101.61M | — |
| Net Income | -$26.74M | -$12.19M | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
BioMarin Pharmaceutical Inc · CIK 1048477 · Engraved from SEC EDGAR
